Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.260
-0.110 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
2.270
+0.010 (0.44%)
After-hours: Dec 5, 2025, 4:10 PM EST
Anebulo Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 93 | 59 | 71 | 60 | 121 | 159 | |
| Market Cap Growth | 134.01% | -16.43% | 17.53% | -50.38% | -23.75% | - | |
| Enterprise Value | 82 | 46 | 66 | 46 | 105 | 159 | |
| Last Close Price | 2.26 | 1.44 | 2.73 | 2.35 | 5.20 | 6.82 | |
| PB Ratio | 9.54 | 5.08 | 18.57 | 5.68 | 8.06 | 7.44 | |
| P/TBV Ratio | 9.54 | 5.08 | 18.57 | 5.68 | 8.06 | 7.44 | |
| Quick Ratio | 10.75 | 23.99 | 11.87 | 10.52 | 28.39 | 82.71 | |
| Current Ratio | 10.93 | 24.53 | 13.46 | 10.92 | 30.40 | 89.61 | |
| Return on Equity (ROE) | -145.11% | -109.69% | -113.80% | -91.42% | -37.42% | -249.85% | |
| Return on Assets (ROA) | -86.11% | -71.09% | -65.97% | -54.05% | -22.93% | -18.30% | |
| Return on Capital (ROIC) | -97.45% | -74.52% | -72.06% | -57.38% | -23.41% | -18.50% | |
| Return on Capital Employed (ROCE) | -93.20% | -79.10% | -217.90% | -111.20% | -45.30% | -16.90% | |
| Earnings Yield | -9.09% | -14.34% | -11.58% | -19.48% | -5.62% | -19.00% | |
| Buyback Yield / Dilution | -45.22% | -30.97% | -2.98% | -7.41% | -71.49% | -13.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.